Metabolism of dietary genotoxins by the human colonic microflora; the fecapentaenes and heterocyclic amines

https://doi.org/10.1016/0165-1110(90)90013-2Get rights and content

Abstract

The microflora of the human colon is a complex ecosystem of anaerobic bacteria which have the capability of enzymatically transforming a variety of dietary (or biliary) compounds to genotoxic metabolites. In the past, most investigators studying the interplay between diet and colonic flora and its role in the etiology of cancers focused on the reductive and glycosidic potential of the bacterial enzymes— many of which reverse the oxidative and conjugative reactions performed by the liver. Recent work in our laboratory has focused on the metabolism of two relatively new classes of genotoxins, the fecapentaenes and the heterocyclic amines (pyrolysis carcinogens). The fecapentaenes (conjugated ether lipids) are produced in the colon by Bacteroides spp. from polyunsaturated ether phospholipids (plasmalogens) whose natural origin and function are unknown. The fecapentaenes are potent direct-acting genotoxins that are detected in the feces of most individuals on normal western diets. The heterocyclic amines, which originate from fried or broiled proteinaceous foods, normally require activation by the liver before being potent mutagens or carcinogens. However, the “IQ” subclass (e.g. IQ and MeIQ) can be activated in the colon by Eubacterium and Clostridium species to a 7-hydroxy form which is directly mutagenic in Salmonella. Although there is no direct evidence that the fecapentaenes or the 7-hydroxy “IQ” compounds influence risk for colon cancer, the potency and prevalence of these bacterial metabolites is cause for concern.

References (87)

  • J.A. Holme et al.

    Comparative genotoxic effects of IQ and MeIQ in Salmonella typhimurium and cultured mammalian cells

    Mutation Res.

    (1987)
  • A.J. Howes et al.

    Effect of dietary fiber on the mutagenicity and distribution of 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ)

    Mutation Res.

    (1989)
  • J.H. Peters et al.

    Mutagenic activities of fecapentaene derivatives in the Ames/Salmonella test system

    Cancer Lett.

    (1988)
  • M.H. Schiffman et al.

    Fecapentaenes and their precursors throughout the bowel—an autopsy study

    Mutation Res.

    (1988)
  • M.H. Schiffman et al.

    Fecapentaene concentrations and mutagenicity in 726 North American stool samples

    Mutation Res.

    (1989)
  • E. Schmid et al.

    Dose-response relationship for chromosomal aberrations induced by fecapentaene-12 in human lymphocytes

    Mutation Res.

    (1987)
  • M. Shioya et al.

    Formation of 8-hydroxyguanosine in DNA treated with fecapentaene-12 and -14

    Mutation Res.

    (1989)
  • P. Sjodin et al.

    A balanced study of 14C-labeled 3H-imidazo[4,5-f]quinolin-2-amines (IQ and MeIQ) in rats

    Fd. Chem. Toxicol.

    (1984)
  • L. Tsai et al.

    Nicotinic acid metabolism, II. The isolation and characterization of intermediates in the fermentation of nicotinic acids

    J. Biol. Chem.

    (1966)
  • R.L. Van Tassell et al.

    Stimulation of mutagen production in human feces by bile and bile acids

    Mutation Res.

    (1982)
  • D.J. Vaughan et al.

    The effect of fecapentaenes on nuclear abberations in murine colonic epithelial cells

    Cancer Lett.

    (1987)
  • S. Venitt

    Mutagens in human feces and cancer of the large bowel

  • W. von der Hude et al.

    Evaluation of the SOS chromotest

    Mutation Res.

    (1988)
  • J.M. Ward et al.

    Inactivity of fecapentaene-12 as a rodent carcinogen or tumor initiator

    Cancer Lett.

    (1988)
  • T.D. Wilkins et al.

    Production of intestinal mutagens

  • T.D. Wilkins et al.

    Characterization of a mutagenic bacterial product in human feces

    Am. J. Clin. Nutr.

    (1980)
  • O.M. Wrong

    Bacterial metabolism of protein and endogenous nitrogen compounds

  • W.S. Barnes et al.

    In vitro binding of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline to dietary fibers

    J. Natl. Cancer Inst.

    (1983)
  • W.S. Barnes et al.

    Genotoxicity of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and analogs

    Carcinogenesis

    (1985)
  • M. Bashir et al.

    Biological formation and chemical synthesis of 2-amino-3,6-dihydro-3-methyl-7H- imidazo[4,5-f]quinoline-7-one, the major metabolite of the dietary carcinogen IQ by normal intestinal bacteria

    Heterocycles

    (1987)
  • M. Bashir et al.

    Isolation, structure elucidation, and synthesis of the major anaerobic bacterial metabolite of the dietary carcinogen 2-amino-3,4-dimethyl-3H-imidazo[4,5-f]quinoline (MeIQ),

    Heterocycles

    (1989)
  • S.C. Booth et al.

    Some factors affecting mutant numbers in the Salmonella/microsome assay

    Carcinogenesis

    (1980)
  • W.R. Bruce et al.

    A mutagen in the feces of normal humans

  • R.J. Carman et al.

    Conversion of IQ, a dietary pyrolysis carcinogen, to a direct-acting mutagen by normal intestinal bacteria of humans

    Mutation Res.

    (1987)
  • M.E. Coates et al.

    Methodological considerations for the study of bacterial metabolism

  • B. Commoner et al.

    Formation of mutagens in beef and beef extract during cooking

    Science

    (1978)
  • R.D. Curren et al.

    Genotoxicity of fecapentaene-12 in bacterial and mammalian cell assay systems

    Carcinogenesis

    (1987)
  • P.P. deWit et al.

    A convenient synthesis of fecapentaene-12 by the Horner-Wittig reaction

    Rec. Trav. Chim. Pays-Bas

    (1984)
  • B.S. Drasar et al.
  • W. Goggleman et al.

    Mutagenicity of synthetic racemic fecapentaene-12

    Mutation Res.

    (1986)
  • P. Goldman

    Biochemical pharmacology and toxicology involving the intestinal flora

  • S.V. Govindan et al.

    Synthesis and biological activity of analogs of fecapentaene-12

    J. Nat. Prod.

    (1987)
  • W.A. Hargraves et al.

    Purification and mass spectral characterization of bacterial mutagens from commercial beef extract

    Cancer Res.

    (1983)
  • Cited by (44)

    • Regulation of Host Chromatin by Bacterial Metabolites

      2016, Chromatin Signaling and Diseases
    • Diet and antioxidant status

      1999, Food and Chemical Toxicology
    View all citing articles on Scopus
    View full text